Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer

INTRODUCTION: The purpose of this study was to retrospectively explore the relationship between human epidermal growth factor receptor 2 (HER2) messenger RNA (mRNA) expression and efficacy in patients receiving trastuzumab plus docetaxel (HT) or trastuzumab emtansine (T-DM1). METHODS: Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Edith A, Hurvitz, Sara A, Amler, Lukas C, Mundt, Kirsten E, Ng, Vivian, Guardino, Ellie, Gianni, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229898/
https://www.ncbi.nlm.nih.gov/pubmed/24887458
http://dx.doi.org/10.1186/bcr3661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229898/
https://www.ncbi.nlm.nih.gov/pubmed/24887458
http://dx.doi.org/10.1186/bcr3661

Ejemplares similares